Acuitive Technologies Receives FDA 510(k) Clearance for CITREPORE™, A New Synthetic Bioactive Bone Void Filler for Orthopedic Procedures Acuitive Technologies announced the FDA 510(k) clearance of CITREPORE™, a new synthetic bioactive bone void filler for orthopedic procedures.

Acuitive Technologies Receives FDA 510(k) Clearance for CITRELOCK DUO a New Sports Medicine Fixation Device for Biceps Tenodesis and Tendon Transfer Procedures ALLENDALE, N.J., September 27, 2023 -- Acuitive Technologies announced the FDA 510(k) Clearance of CITRELOCK DUO Fixation Device for biceps tenodesis

Acuitive Technologies Launches New Tendon Fixation Device for Sports Medicine Citrelock® Differentiated Biomaterial and Design Features ALLENDALE, N.J., June 29, 2023 (GLOBE NEWSWIRE) -- Acuitive Technologies, Inc. (Acuitive) today announced the first surgical use of its...

Two Industry Veterans Join Acuitive Technologies, Inc. Board of Directors as Independent Members ALLENDALE, N.J., March 13, 2023 (GLOBE NEWSWIRE) -- Acuitive Technologies announced that Vince Forlenza and Gary Fischetti will join their Board of Directors. Both bring decades of medical...